ACAD (ACADIA Pharmaceuticals Inc) Net earnings per share (EPS TTM)
The TTM net income per share metric demonstrates the dynamics of per-share earnings, where the value of 2.09 characterizes this level. The biopharmaceutical business of ACAD Pharmaceuticals (ACAD) focuses on the therapy of CNS disorders, leveraging exclusive rights to unique drugs. The company monetizes treatments for Parkinson's disease psychosis and is expanding into the Rett syndrome segment. The absence of direct analogs ensures premium pricing power, which is offset by insurance reimbursements.
Comprehensive metric breakdowns and analytics for ACADIA Pharma (ACAD)
- stock price and consensus target price:
- business market valuation indicators:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Debt to Equity ACADIA Pharmaceuticals|ACAD - Long-Term Liabilities to Equity|Short-Term Debt to Capital ACADIA Pharmaceuticals Inc|ACAD - Aggregate Debt Obligations|Debts to Book Capitalization ACADIA Pharmaceuticals Inc.|ACAD - Company Long-Term Debts|Company Short-Term Debt ACADIA Pharmaceuticals|Quick Liquidity acadia-pharm.com
- net income and valuation multiples indicators:
ACAD - Net Income|Projected Future Earnings ACADIA Pharmaceuticals|ACAD - P/E Multiple|Forward P/E Multiple ACADIA Pharmaceuticals Inc.|ACAD - Price/Earnings to Growth Multiple|EV/EBITDA Multiple ACADIA Pharmaceuticals Inc.|ACAD - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months ACADIA Pharmaceuticals|ACAD - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months acadia-pharm.com|ACAD - Net earnings per one share growth for the current year|Earnings growth forecast for next year ACADIA Pharmaceuticals
- sales and revenue data:
General company analysis:ACADIA Pharmaceuticals (ACAD)
To identify the sector's fundamental leaders, the analyst evaluates EPS TTM as net income allocated per share over a year, which allows for filtering out market noise and measuring the security's real yield. Amid geopolitical risks hindering component logistics and ACADIA Pharmaceuticals (ACAD) clinical trials, the 12-month earnings per share history helps distinguish a temporary drawdown from a systemic production crisis.
Competitors of ACADIA Pharmaceuticals (ACAD)
Biogen Inc. - Net earnings per share (EPS TTM)|NBIX (neurocrine.com) - Earnings per share for the last 12 months|RGC: Net earnings per share (EPS TTM)|AXSM - Net earnings per share for the last four quarters|XENE (Xenon Pharmaceuticals Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Viking Therapeutics Corp|Net earnings per share for the last 12 months SUPN (Supernus Pharmaceuticals)|CPRX (catalystpharma.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Denali Therapeutics Inc. DNLI|HRMY (Harmony Biosciences Inc) - Earnings per one share for the last 12 months|Biohaven Pharmaceutical - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AMLX (Amylyx Corp)|TRVI: Net earnings per share (EPS TTM)|praxismedicines.com (PRAX) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Anavex Life Sciences Corp.|CBLL: Earnings per share for the trailing year|Earnings per share for the last twelve months Prothena Corp (PRTA)|Net earnings per share for the last 12 months alector.com ALEC|Net earnings per share (EPS TTM) ANNX (Annexon, Inc.)|Net earnings per share (EPS TTM) Omeros Corp OMER|Neurogene - Net earnings per share (EPS TTM)|AC Immune S.A. (ACIU) - Net earnings per share for the last 12 months|VYGR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Neumora Corp (NMRA)|Net earnings per share for the last 12 months SCLX|Net earnings per share (EPS TTM) tevogen.com|Net earnings per share for the last 12 months ACOG (Alpha Cognition)|Earnings per share for the last four quarters CGTX|Net earnings per share (EPS TTM) IKT (Inhibikase)|Net earnings per share for the last four quarters Cassava Pharma (SAVA)|Assertio Therapeutics - Net earnings per share (EPS TTM)|Coya Therapeutics, Inc. (COYA) - Net earnings per share for the last 12 months|VTGN: Net earnings per share (EPS TTM)|Ovid Therapeutics (OVID) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Acumen Pharma|Earnings per share for the last twelve months CRVO|Earnings per share for the last twelve months Alterity Therapeutics (ATHE)|Net earnings per share for the last four quarters clene.com|Net earnings per share (EPS TTM) PEPG (PepGen)|Net earnings per share (EPS TTM) Jupiter Neurosciences, Inc. JUNS|Relmada - Net earnings per share (EPS TTM)|Annovis Bio Corporation (ANVS) - Net earnings per share for the last 12 months|GRCE: Net earnings per share (EPS TTM)|fireflyneuro.com (AIFF) - Net earnings per share (EPS TTM)|KLTO (ANEW Medical) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months NRSN (NeuroSense Therapeutics, Ltd.)|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings (RVPH)|metaviatx.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NRXS (NeurAxis, Inc.)|Helius Medical Technologies, Inc. (HSDT) - Net earnings per one share for the last twelve months|PASG: Net earnings per share for the last 12 months|NEUP - Net earnings per share (EPS TTM)|Minerva Neurosciences Corp (NERV) - Earnings per share for the last twelve months|Athira Pharma Corp - Earnings per share for the trailing year|Earnings per share for the last twelve months Addex Therapeutics|Net earnings per one share for the last twelve months Alzamend ALZN|Net earnings per share (EPS TTM) CYCN|Net earnings per share (EPS TTM) protagenic.com (PTIX)|Net earnings per share (EPS TTM) KTTA (Pasithea Therapeutics Corp.)|CRGT - Net earnings per share for the last 12 months|Avenue Therapeutics - Net earnings per share (EPS TTM)|BCLI - Net earnings per share (EPS TTM)|CARA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CHRO|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Intra-Cellular (ITCI) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) LBPH|Net earnings per share (EPS TTM) marinuspharma.com (MRNS)|NKGen Biotech - Net earnings per share for the last 12 months|Earnings per share for the trailing year NRBO|SAGE - Earnings per share for the last twelve months|Earnings per one share for the last 12 months SNPX|TRVN: Net earnings per share (EPS TTM)|Vigil Neuroscience, Inc. - Earnings per share for the trailing year|WENA (Anew Medical) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Cerevel Therapeutics Inc
